Request Deal Involvement

CB Biotechnology to acquire Theratechnologies for up to $254m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Barclays

financial advisors

Barclays

Raymond James

financial advisors

Raymond James

Fasken

legal advisors

Fasken

Norton Rose Fulbright

legal advisors

Norton Rose Fulbright

Bourne Partners

financial advisors

Bourne Partners

Honigman Miller Schwartz & Cohn

legal advisors

Honigman Miller Schwartz & Cohn

McMillan

legal advisors

McMillan

DPO&Co

commercial advisors

DPO&Co

or

Principals

THERATECHNOLOGIES INC

target

THERATECHNOLOGIES INC

FUTURE PAK LLC

bidder

FUTURE PAK LLC

CB BIOTECHNOLOGY

bidder

CB BIOTECHNOLOGY

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite